Sight Sciences

Join us at AAO in Chicago, booth 4019, from October 19 to 21 for an exciting lineup of activities, including OMNI and SION demonstrations, case presentations, learning skills labs, TearCare® Clearance Experiences, clinical collaborations, and reimbursement discussions. We look forward to seeing you soon! See a list of our activities at AAO at www.sightsciences.com/aao

Love your eyes, protect your sight! Today, on World Sight Day (October 10), we join the global effort to raise awareness about eye health and inspire people to take care of their vision. At Sight Sciences, our mission is to develop transformative, interventional technologies that allow eyecare providers to procedurally elevate the standards of care – empowering people to keep seeing. Learn more about World Sight Day here: https://lnkd.in/eNGA4Dz3 #WorldSightDay #WorldSightDay2024 #LoveYourEyes #KeepSeeing

Greetings from Berlin and Southampton! Our German team (first photo) is representing us at the DOG Congress in Berlin, while our UK team (second photo) is at the UKEGS meeting in Southampton. Both teams are sharing insights on how our OMNI technology is transforming MIGS and advancing the interventional mindset in eyecare!

We had a fantastic and productive time at #ASCRS2024 earlier this year, connecting with colleagues, customers, and industry friends. Now, we are excited to welcome you to our booth at #AAO2024 in Chicago from October 19-21! Join us for an engaging lineup of activities, including live demos, presentations, learning labs, clinical collaborations, and reimbursement discussions. We hope to see you there! Learn more at https://lnkd.in/gNfTKRdw

Thank you, Dr. Avneet Sodhi Gaur and Dr. Douglas McGraw, for visiting us today and spending time with our R&D team. It’s always a pleasure to collaborate and drive innovation forward together!

Congratulations to Dr. Clarke Nelson, Dr. Tommy Dang, Dr. Regis Rumpf, and Dr. Judd Cahoon on completing the clinical and surgical training for the OMNI® Surgical System! We are honored to partner with these outstanding surgeons and excited to welcome them and their teams to the Sight Sciences family. Together, we are reimagining eyecare with transformative technology and an interventional mindset. Thank you for your partnership—we look forward to continued success together!   Clarke Nelson, MD, PhD Katzen Eye Group Lutherville, MD   Tommy Dang, MD Mid-Atlantic Eye Care Williamsburg, VA   Regis Rumpf, MD North Park Ophthalmology Pittsburgh, PA   Judd Cahoon, MD, PhD Astorino & Associates Eye Center Newport Beach, CA We also thank our colleagues—Alana Woodard, Chris Anderson, Chris Faith, Carrie McMullin, Justyn Stormes—for their dedication in helping eyecare providers to procedurally elevate the standards of care! Contact your local Sight Sciences rep to learn more about our training programs.   . . . . . . . . . . The OMNI® Surgical System is indicated for canaloplasty (microcatheterization and transluminal viscodilation of Schlemm’s canal) followed by trabeculotomy (cutting of trabecular meshwork) to reduce intraocular pressure in adult patients with primary open-angle glaucoma. Visit www.sightsciences.com/omni for more information and the indications for use, contraindications, warnings, and potential adverse events. #omnisurgical #migs #glaucoma #ophthalmology #omnicertification

In this Healio Video Perspective from the Women in Ophthalmology meeting, Anita Campbell, MD, of Stiles Eyecare Excellence, discusses 24-month study outcomes with the OMNI surgical system. “The results are very promising. The OMNI Surgical System was shown to be a great intervention,” said Dr. Campbell. Thank you, Dr. Campbell, for your valuable insights and your dedication to studying OMNI! We invite you to watch it! https://lnkd.in/gd3MRrTN . . . . . . . . . . Dr. Anita Campbell is a paid consultant of Sight Sciences. The OMNI® Surgical System is indicated for canaloplasty (microcatheterization and transluminal viscodilation of Schlemm’s canal) followed by trabeculotomy (cutting of trabecular meshwork) to reduce intraocular pressure in adult patients with primary open-angle glaucoma. Visit omnisurgical.com/ifu for the indications for use, contraindications, warnings, and potential adverse events. All ORION clinical study data on file at Sight Sciences. Jaime E Dickerson; Kenneth Olander; Mark F Pyfer; Alison Harvey. Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):1926. OM-3259-US.v1 #omnisurgical #glaucoma #migs #wio2024 #ophthalmology #eyecare #ophthalmologists #omnisurgical

Did you know Sight Sciences was founded by two brothers? In a conversation with Neda Shamie, MD, and Ophthalmology Times, our CEO, Paul Badawi, shared the pivotal moment that inspired him and his ophthalmologist brother, David Badawi, MD, to reimagine eye care and establish Sight Sciences. Watch the full discussion to learn more about our company’s history, Paul’s journey, and the innovative drive behind Sight Sciences! https://lnkd.in/eH_vbJNz #SightSciences #eyecare #ophthalmology

Here are a few more highlights from our fantastic experience at #ESCRS2024. We proudly supported the ‘MIGS without implants’ dry lab course and welcomed learners to our booth for hands-on sessions at our ‘Accelerated Learning Centre,’ where they enhanced their skills and deepened their understanding of OMNI. Additionally, we were honored to be joined by Professor Fritz Hengerer, Dr. Andrew Tatham, and Ms. Nishani Amerasinghe, who shared insights on the GEMINI study, patient selection, and the importance of early intervention.

Our Chief Commercial Officer, Matt Link (far right in the picture), proudly represented Sight Sciences at the Ophthalmology Futures Forum 2024 in Barcelona. Matt joined industry leaders in insightful discussions on the future of ophthalmic surgery and innovation's pivotal role in advancing technologies and procedures. If you are attending #ESCRS2024, stop by our booth (C7.12, Hall 7) to discover how we are reimagining eyecare with transformative technology and an interventional mindset. We look forward to seeing you there! #ophthalmology #eyecare #ophthalmicsurgery #glaucoma #ophthalmologyfuturesforum